Society guideline links: Pediatric thyroid disorders

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Thyroid nodules and cancer" and "Society guideline links: Hyperthyroidism" and "Society guideline links: Hypothyroidism".)

International

●Recommendations for diagnosis and treatment of pseudohypoparathyroidism and related disorders – An updated practical tool for physicians and patients (2020)

•Diagnosis and management of pseudohypoparathyroidism and related disorders – First international consensus statement (2018)

●Endocrine Society (ES): Clinical practice guideline on hypothalamic–pituitary and growth disorders in survivors of childhood cancer (2018)

United States

●Pediatric Endocrine Society (PES): Statement on thyroid monitoring in infants and young children receiving iodine-containing contrast media (2022)

●PES: Referral guidelines for the child with abnormal newborn screen for congenital hypothyroidism (2021)

●PES: Referral guidelines for the child with suspected acquired hypothyroidism (2021)

●PES: Referral guidelines for the child with suspected hyperthyroidism (2021)

●PES: Referral guidelines for the infant with suspected congenital hypothyroidism (2020)

●PES: Referral guidelines for the infant with suspected hyperthyroidism (2020)

●American Thyroid Association (ATA): Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis (2016)

●ATA: Guidelines for the treatment of hypothyroidism (2014)

Europe

●European Thyroid Association (ETA): Guideline for the management of pediatric Graves' disease (2022)

●Endo-European Reference Network (ENDO-ERN): Congenital hypothyroidism – 2020-2021 consensus guidelines, update (published 2021)

●ETA: Guidelines for the management of iodine-based contrast media-induced thyroid dysfunction (2021)

●ETA: Guidelines on the management of thyroid dysfunction following immune reconstitution therapy (2019)

●ETA: Guideline for the management of Graves' hyperthyroidism (2018)

●ETA: Guidelines for the management of amiodarone-associated thyroid dysfunction (2018)

●ETA: Guidelines on the diagnosis and management of central hypothyroidism (2018)

●ETA/European Group on Graves' Orbitopathy (EUGOGO): Guidelines for the management of Graves' orbitopathy (2016)

●European Society for Paediatric Endocrinology (ESPE): Consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism (2014)

●ETA: Guidelines for the management of subclinical hypothyroidism in pregnancy and in children (2014)

●ETA: Guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations (2012)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on thyroid disease – Assessment and management (2019, updated 2023)

●Down Syndrome Medical Interest Group (DSMIG): Thyroid disorder in children and young people with Down syndrome – Surveillance and when to initiate treatment (2020)

●NICE: Guideline on hyperparathyroidism (primary) – Diagnosis, assessment, and initial management (2019)

●British Thyroid Association (BTA): Statement on the management of primary hypothyroidism (2015)

●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline for the long term follow up of survivors of childhood cancer (2013)

India

●Indian Society for Pediatric and Adolescent Endocrinology (ISPAE): Congenital hypothyroidism guidelines (2018)

Australia–New Zealand

●Choosing Wisely Australia: Don't test thyroid function as population screening for asymptomatic patients (2016)

●Choosing Wisely Australia: Don't order a total or free T3 level when assessing thyroxine dose in hypothyroid patients (2015)

●Choosing Wisely Australia: Don't routinely order a thyroid ultrasound in patients with abnormal thyroid function tests if there is no palpable abnormality of the thyroid gland (2015)

Japan

●Japan Thyroid Association (JTA) and Japan Endocrine Society (JES): Guidelines for the management of thyroid storm, 1st edition (2016)

●Japanese Society for Pediatric Endocrinology (JSPE) and JTA: Guidelines for the treatment of childhood-onset Graves' disease in Japan (2016)

●JSPE and Japanese Society for Mass Screening: Guidelines for mass screening of congenital hypothyroidism, 2014 revision (published 2015)